| 1 |
Ronald Knegtel |
Vertex Pharmaceuticals Incorporated |
6 |
| 2 |
David Festus Charles Moffat |
Chroma Therapeutics |
4 |
| 3 |
Mark James Batchelor |
Vertex Pharmaceuticals Incorporated |
3 |
| 3 |
Elizabeth Jane Acosta |
Sharp Kabushiki Kaisha |
3 |
| 3 |
Ian Bell |
Infineum International Limited |
3 |
| 3 |
Jonathan Mark Bentley |
Vernalis Research Limited |
3 |
| #7 |
Andrew James Hudson |
Sharp Kabushiki Kaisha |
2 |
| #7 |
Julian M. C. Golec |
Vertex Pharmaceuticals Incorporated |
2 |
| #7 |
Nathaniel Julius Thomas Monck |
Vernalis Research Limited |
2 |
| #7 |
Andrew Miller |
Vertex Pharmaceuticals Incorporated |
2 |
| #7 |
Ramah J. Brod |
ExxonMobil |
2 |
| #7 |
Petra Dieterich |
American Cyanamid |
2 |
| #13 |
Stephen Coulson |
P2I |
1 |
| #13 |
John Oliver Wilson Norris |
Accentus Plc |
1 |
| #13 |
Timothy James Calver |
Regenesys Technologies Limited |
1 |
| #13 |
Paul Goulding |
Oxford Glycosystems Limited |
1 |
| #13 |
Christopher Plush |
Orange Personal Communication Services Limited |
1 |
| #13 |
Nigel Alastair Dent |
ICI |
1 |
| #13 |
Christopher David John Manson-Whitton |
Accentus Plc |
1 |
| #13 |
John Michael Tiffany |
Isis Innovation Limited |
1 |
| #13 |
Timothy Foster |
Good Humor-Breyers Ice Cream, Division Of Conopco |
1 |
| #13 |
Orde Levinson |
— |
1 |
| #13 |
Allan Peter Smith |
Accentus Plc |
1 |
| #13 |
Jane Galsworthy |
Infineum International Limited |
1 |
| #13 |
Daryl Simon Walter |
Glaxo Group Limited |
1 |
| #13 |
Brian William Davies |
ExxonMobil |
1 |
| #13 |
Zsolt John Laczik |
Isis Innovation Limited |
1 |
| #13 |
Eric Evans |
Analog Devices |
1 |
| #13 |
Min Huang |
Jiangnan University |
1 |
| #13 |
Graham Michael Wynne |
Oxagen Limited |
1 |
| #13 |
Adrian Hill |
Isis Innovation Limited |
1 |